Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

264 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype.
Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, Mohs RC, Sheu RK, Blass JP. Gibson GE, et al. Ann Neurol. 2000 Sep;48(3):297-303. Ann Neurol. 2000. PMID: 10976635
Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population.
Sheu KF, Brown AM, Haroutunian V, Kristal BS, Thaler H, Lesser M, Kalaria RN, Relkin NR, Mohs RC, Lilius L, Lannfelt L, Blass JP. Sheu KF, et al. Ann Neurol. 1999 Jan;45(1):48-53. Ann Neurol. 1999. PMID: 9894876
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V. Davis KL, et al. JAMA. 1999 Apr 21;281(15):1401-6. doi: 10.1001/jama.281.15.1401. JAMA. 1999. PMID: 10217056
Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline.
Parvathy S, Davies P, Haroutunian V, Purohit DP, Davis KL, Mohs RC, Park H, Moran TM, Chan JY, Buxbaum JD. Parvathy S, et al. Arch Neurol. 2001 Dec;58(12):2025-32. doi: 10.1001/archneur.58.12.2025. Arch Neurol. 2001. PMID: 11735776
Oral physostigmine treatment of patients with Alzheimer's disease.
Mohs RC, Davis BM, Johns CA, Mathé AA, Greenwald BS, Horvath TB, Davis KL. Mohs RC, et al. Am J Psychiatry. 1985 Jan;142(1):28-33. doi: 10.1176/ajp.142.1.28. Am J Psychiatry. 1985. PMID: 3881051 Clinical Trial.
Induction of depression with oxotremorine in patients with Alzheimer's disease.
Davis KL, Hollander E, Davidson M, Davis BM, Mohs RC, Horvath TB. Davis KL, et al. Am J Psychiatry. 1987 Apr;144(4):468-71. doi: 10.1176/ajp.144.4.468. Am J Psychiatry. 1987. PMID: 3565616
L-deprenyl and physostigmine for the treatment of Alzheimer's disease.
Marin DB, Bierer LM, Lawlor BA, Ryan TM, Jacobson R, Schmeidler J, Mohs RC, Davis KL. Marin DB, et al. Psychiatry Res. 1995 Oct 16;58(3):181-9. doi: 10.1016/0165-1781(95)02714-8. Psychiatry Res. 1995. PMID: 8570774 Clinical Trial.
RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects.
Hollander E, Davidson M, Mohs RC, Horvath TB, Davis BM, Zemishlany Z, Davis KL. Hollander E, et al. Biol Psychiatry. 1987 Sep;22(9):1067-78. doi: 10.1016/0006-3223(87)90049-7. Biol Psychiatry. 1987. PMID: 3651528 Clinical Trial.
Cholinergic strategies in the treatment of Alzheimer's disease.
Davidson M, Stern RG, Bierer LM, Horvath TB, Zemishlani Z, Markofsky R, Mohs RC. Davidson M, et al. Acta Psychiatr Scand Suppl. 1991;366:47-51. doi: 10.1111/j.1600-0447.1991.tb03109.x. Acta Psychiatr Scand Suppl. 1991. PMID: 1897375 Review.
264 results
Jump to page